PRP vs. Stem Cell Therapy: Which Is Right for You?
Platelet-rich plasma and cell-based therapies are often discussed together, but they work differently and suit different patients. Here's how to tell which is the better fit.
TL;DR
PRP and cell-based ("stem cell") therapies are both injection-based regenerative treatments, but they use different starting materials and tend to fit different patient profiles. PRP is often the first-line regenerative choice for milder cases; cell-based therapies are typically reserved for more advanced disease or cases where PRP hasn't been enough. The right answer depends on your imaging, your symptoms, and your goals.
How each one is made
PRP (Platelet-Rich Plasma)
- A small amount of your blood is drawn (similar to a standard blood test).
- It's spun in a centrifuge to concentrate the platelets.
- The concentrate is injected — usually under ultrasound guidance — directly into the joint or tendon.
Platelets carry hundreds of growth factors involved in tissue repair.
Cell-based therapy
- Cells are sourced from your bone marrow, your adipose tissue, or ethically sourced perinatal tissue.
- The sample is processed to concentrate the relevant cells and signaling molecules.
- The product is injected into the target tissue.
Cell-based products contain a broader mix of biologically active components than PRP.
When PRP tends to be the better fit
- Mild-to-moderate osteoarthritis
- Tendinopathy (tennis elbow, patellar tendinopathy, Achilles)
- Partial ligament injuries
- Patients with strong intrinsic healing capacity
- Patients who want to start with the most-studied, lowest-cost option
The 2021 American Journal of Sports Medicine meta-analysis found PRP outperformed hyaluronic acid for knee OA pain at both 6 and 12 months.
When cell-based therapy tends to be the better fit
- Moderate-to-advanced osteoarthritis
- Patients who tried PRP and got partial but incomplete relief
- Larger or more chronic soft-tissue injuries
- Patients trying to delay or avoid joint replacement
A 2023 systematic review in Cartilage concluded that cell-based knee injections produced clinically meaningful pain and function improvements at 12 months versus placebo and hyaluronic acid.
Side-by-side comparison
| Factor | PRP | Cell-based |
|---|---|---|
| Source | Your blood | Bone marrow, adipose, or perinatal tissue |
| Best for | Mild-to-moderate cases, tendinopathy | Moderate-to-advanced cases |
| Onset | 4–12 weeks | 6–16 weeks |
| Typical duration | 6–12+ months | 12–24+ months |
| Sessions | Often 1–3 | Often 1–3 |
| Relative cost | Lower | Higher |
| Evidence base | Strongest in joint OA | Growing, robust in moderate OA |
Can you combine them?
Yes — some protocols layer PRP onto a cell-based product to combine the broader signaling of cells with the growth-factor boost of PRP. Whether this is right for you depends on your specific diagnosis and the clinician's evaluation.
What about safety?
Both therapies have favorable published safety profiles when administered by trained clinicians using compliant products. Most adverse events are minor — soreness, swelling, or a transient inflammatory flare for 24–72 hours. Serious complications are rare.
How a clinician actually decides
A reasonable decision process looks at:
- Imaging. What does the joint or tissue actually look like?
- Severity and chronicity. How long has the pain been present, and how is it limiting you?
- Prior treatments. What's already been tried, and how did it work?
- Goals. Are you trying to get back to a sport, stay mobile for grandkids, or delay a planned surgery?
- Budget. What's realistic for you?
A reputable clinic will not push you toward the more expensive option without a clinical reason to do so.
Bottom line
There's no universally "better" regenerative therapy — there's the one that fits your tissue, your condition, and your goals. The right way to decide is a real exam, a look at your imaging, and an honest conversation with a clinician.
Call 252-765-PAIN for a free consultation.
Which is better, PRP or stem cell therapy?
Neither is universally better — the right choice depends on your specific condition, imaging, and goals. PRP is often the first-line regenerative choice for milder cases; cell-based therapies are commonly reserved for more advanced disease.
Is one more expensive than the other?
Yes — cell-based therapies are typically more expensive than PRP because of the source material and processing involved. We provide an exact price at your consultation.
Can I do PRP first and cell-based later?
Yes. Many patients start with PRP and step up to cell-based therapy if the response is partial. Your clinician will guide the decision based on your follow-up evaluation.
How long until I feel a difference?
PRP often shows benefit in 4–12 weeks; cell-based therapies often take 6–16 weeks for full effect, with continued improvement over several months.